2. Home
  3. Video Lectures
  4. mCRPC Treatment

mCRPC Treatment

mCRPC Treatment
A Clinical Conversation with Alicia Morgans and Charles Ryan: Considerations of ASCO 2017 LATITUDE and STAMPEDE
June 21, 2017
Details
mCRPC Treatment
Therapeutic Layering in Optimizing Treatment for Patients With CPRC (RADAR 2)- Phillip Koo
May 23, 2017
Details
mCRPC Treatment
IMAAGEN Trial Update: Effect of Abiraterone Acetate and Low Dose Prednisone on PSA in Patients with Non-Metastatic Castration-Resistant Prostate Cancer - Charles Ryan
July 28, 2016
Details
mCRPC Treatment
Abiraterone in Elderly Chemotherapy-Naive Patients with mCRPC - Charles Ryan
April 28, 2016
Details
mCRPC Treatment
Charles Ryan on mCRPC Treatment: Combination Therapy - Clinical Case
April 26, 2016
Details
mCRPC Treatment
Charles Ryan on mCRPC Treatment: When to Start Abiraterone?
April 26, 2016
Details
mCRPC Treatment
Assessment of Corticosteroid-Associated Adverse Events With Long Term Exposure to Low-Dose Prednisone Given With Abiraterone Acetate to mCRPC Patients - Charles Ryan
January 7, 2016
Details
mCRPC Treatment
Delay Chemotherapy in Hormone Sensitive Metastatic Prostate Cancer - Michael Cookson
April 1, 2016
Details
mCRPC Treatment
Peter Scardino on A Century of Progress in Urologic Cancers 1915-2015 - MSKCC
September 3, 2015
Details
mCRPC Treatment
Charles Ryan on Practical Considerations in the Use of Novel Hormone Agents in the Post-ADT Setting
August 17, 2015
Details
mCRPC Treatment
William Lowrance on AUA Guideline: Castration-resistant Prostate Cancer Update
May 19, 2015
Details
mCRPC Treatment
Journal Club: Final OS Analysis of COU-AA-302 - Abiraterone in mCRPC without Prior Chemo - Charles Ryan
March 27, 2015
Details
mCRPC Treatment
Radiographic Progression-free Survival as a Response Biomarker in mCRPC: COU-AA-302 Results - Charles Ryan
March 7, 2015
Details
mCRPC Treatment
Alicia Morgans on Transitions in Treating mCRPC: Abiraterone after Sipuleucel-T
February 21, 2015
Details
mCRPC Treatment
Selection of Systemic Therapy: Chemotherapy and Androgen Axis Agents - Evan Yu
March 11, 2015
Details
mCRPC Treatment
Lower Tumor Burden Patient with Progression after Sipuleucel-T, Treated with Abiraterone Acetate - Charles Ryan
January 16, 2015
Details
mCRPC Treatment
Thomas Keane on NCCN Guidelines Update - 2015
December 2, 2014
Details
mCRPC Treatment
Final OS Analysis of COU-AA-302 - Study of Abiraterone Acetate in mCRPC without Prior Chemo - Charles Ryan
October 28, 2014
Details
mCRPC Treatment
Understanding Antigen Spreading in Immunotherapy
August 6, 2014
Details
mCRPC Treatment
Chemohormonal Therapy vs. Hormonal Therapy for Hormone-sensitive mPrCa
June 27, 2014
Details
mCRPC Treatment
The Art and Science of Treating Men with CRPC
June 11, 2014
Details
mCRPC Treatment
Final Analysis of Early Access Protocol with AA in mCRPC Patients
June 3, 2014
Details
mCRPC Treatment
PSMA Antibody Drug Conjugate in Taxane-treated mCRPC
April 14, 2014
Details
mCRPC Treatment
Potential Sequencing of Newer Agents for mCRPC
March 28, 2014
Details
mCRPC Treatment
Novel Hormonal Therapies
March 27, 2014
Details
mCRPC Treatment
State-of-the-Art Advanced Treatment Landscape
March 20, 2014
Details
mCRPC Treatment
Sequencing Therapy in Advanced PCa: Focus on Sip-T
March 16, 2014
Details
mCRPC Treatment
Treatment of Progressing mCRPC
March 11, 2014
Details
mCRPC Treatment
Oral Androgen Receptor Pathway Agents are Changing PCa+ Treatment
February 24, 2014
Details
mCRPC Treatment
Androgen Resistance - The Dream Team Research
February 7, 2014
Details
mCRPC Treatment
mCRPC PRO
December 3, 2013
Details
mCRPC Treatment
Abiraterone Acetate: Evolving Treatment for Metastatic CRPC
November 23, 2013
Details
mCRPC Treatment
PSA Changes as a Surrogate for OS in Men with mCRPC
November 21, 2013
Details
mCRPC Treatment
The Changing Role of the Urologist
October 30, 2013
Details
mCRPC Treatment
Treatment of mCRPC Pre-chemotherapy
September 14, 2013
Details
mCRPC Treatment
Treatment of mCRPC
September 13, 2013
Details
E-Newsletters

Stay Connected

Signup to receive urology industry news and updates via email